Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Flavonoids as Nutraceuticals: A Review
2008619 citationsDM Sakarkar et al.Tropical Journal of Pharmaceutical Researchprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of DM Sakarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DM Sakarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DM Sakarkar more than expected).
This network shows the impact of papers produced by DM Sakarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DM Sakarkar. The network helps show where DM Sakarkar may publish in the future.
Co-authorship network of co-authors of DM Sakarkar
This figure shows the co-authorship network connecting the top 25 collaborators of DM Sakarkar.
A scholar is included among the top collaborators of DM Sakarkar based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with DM Sakarkar. DM Sakarkar is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sakarkar, DM, et al.. (2010). Absorbance Correction and Vierodt's Spectrophotometric Methods for the Simultaneous Determination of Ofloxacin and Nitazoxanide in Combined Tablet Dosage Form. 3(1). 214–216.1 indexed citations
7.
Sakarkar, DM, et al.. (2009). Galangoisoflavonoid Isolated from Rhizomes of Alpinia Galanga. Pharmacognosy Magazine. 5(19). 209–212.1 indexed citations
Sakarkar, DM, et al.. (2008). Stability Indicating RP- HPLC Method for Simultaneous Estimation of Valsartan and Amlodipine in Capsule Formulation.. Asian Journal of Research in Chemistry. 1(1). 15–18.51 indexed citations
Sakarkar, DM, et al.. (2008). Flavonoids as Nutraceuticals: A Review. Tropical Journal of Pharmaceutical Research. 7(3).619 indexed citations breakdown →
16.
Chitlange, Sohan S., et al.. (2008). A stability-indicating reverse phase high performance liquid chromatography method for the simultaneous determination of ramipril and valsartan in pharmaceutical dosage form. 1(3). 215–217.4 indexed citations
17.
Sakarkar, DM, et al.. (2008). Development and Evaluation of Sustained Release Matrix Tablets Using Natural Polymer as Release Modifier. 1(3). 193–196.9 indexed citations
18.
Sakarkar, DM, et al.. (2008). Formulation and In-vitro Evaluation of Rapidly Disintegrating Tablets Using Hydrochlorothiazide as a Model Drug. 1(4). 349–352.15 indexed citations
19.
Sakarkar, DM, et al.. (2004). Wound healing properties of Henna leaves.20 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.